Ginkgo Bioworks Holdings Inc vs Energy Select Sector SPDR Fund — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while Energy Select Sector SPDR Fund trades at $56.88. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | XLE | |
|---|---|---|
Market Cap | $590.53M | — |
Sector | Health | — |
52-Week High | $16.14 | $62.57 |
52-Week Low | $5.48 | $42.12 |
Enterprise Value | $627.78M | — |
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
XLE trades at $56.75, up 3.03% with a bullish technical signal from moving averages and oscillators. The ETF benefits from strong sector performance, ranking among top Sector SPDRs with 21% YTD gains (ETF Trends, July 2, 2026). Recent oil price volatility and geopolitical tensions drive energy sector attention, while a dividend of $0.38 is scheduled for June 2026.
Outlook remains positive due to robust earnings growth expectations in energy, though overbought RSI signals near-term caution. Risks include oil price sensitivity and competition from clean energy ETFs. Analyst sentiment leans bullish with sector fundamentals strengthening amid disciplined capital expenditure and demand drivers.
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →